Table 7 Multivariate analysis for progression free survival after ipilimumab
Predictor | Level | HR | HR 95% CI | P-value |
|---|---|---|---|---|
LDH | ≤ULN | 1 | – | 0.738 |
>ULN | 1.12 | [0.58, 2.14] | ||
Stage | not M1c | 1 | – | 0.431 |
M1c | 1.32 | [0.66, 2.67] | ||
MTV | ≤41 | 1 | – | 0.334 |
> 41 | 1.39 | [0.71, 2.70] | ||
ALC | ≤1 | 1 | – | 0.083 |
> 1 | 0.55 | [0.28, 1.06] | ||
SLR | ≤1.1 | 1 | – | 0.042 |
> 1.1 | 2.67 | [1.13, 6.33] |